Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
132 Leser
Artikel bewerten:
(0)

OTC Daily Trading News: Alkame Holdings, Inc. Sino Argo Food, Inc. Vuzix Corp, Sigma Labs, Inc. Asterias Biotherapeutics, Inc.

LONDON, September 10, 2014 /PRNewswire/ --

Alkame Holdings (OTC: ALKM) was the big mover in the OTC markets ahead of the open today. Shares closed higher by 167% yesterday and traded even higher on an intraday basis. The company announced an expansion with a new sales force into Hawaii and the markets seemed to like the news. The sell off into the afternoon session could be put down to profit taking and will be interesting to see the open on Alkame in today's trading. For our latest commentary on Alkame Holdings please click here.

Sino Argo Foo (OTC: SIAF) enjoyed a higher day on three times its normal daily volume as shares closed higher by 4.3% on almost 2 million shares. Shares have been in a firm uptrend all month as they recently announced a convertible debt offering. The 52 week high is now in sight for traders and could be achieved this week.

If you are looking to receive our latest weekly picks as well as the latest news from the OTC markets sent directly to your inbox we invite you to sign up directly at Super Stock Profits or by copy and pasting the following into your browser http://www.superstockprofits.com

Vuzix Corp (OTC: VUZI) closed right at the highs of the day and in the green by more than 4% in a busy day for shares where twice as many exchanged hands on the OTCBB. With the stock edging higher each month since the June timeframe this could be another stock on its way to a new high in the near future. For our recent commentary on VUZI please click here.

Sigma Labs (OTC: SGLB) announced the release of their latest software and shares closed up by 4.5% as that stock continued to move to the upside on increased volume. With nearly 4 million shares exchanging hands and a close above the resistance point, the week ahead looks good for Sigma Labs.

Asterias Biotherapeutics (OTC: ASTY) as one of the heaviest traded pink sheets in the market after trading 1.4 million shares, however was slightly lower on the day. An expected pullback after such a strong run recently in the stock, short term traders will see this as an opportunity if the volume stays high. For our latest opinion and news on ASTY please click here.

Super Stock Profits releases our latest penny stock picks along with the top trading volume and percentage leader plays within the small cap markets - keeping you up to date with the latest picks and the latest news on the stocks in focus.

Disclosure: http://www.superstockprofits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities but for informational purposes only. Investors should always conduct their own due diligence with any potential investment. Super Stock Profits is affiliated with AMG Global Advisors Ltd which is a FINRA registered company (168847). We have not been compensated by any of the companies listed in this news release

Email: info@superstockprofits.com

Tel: +1-561-866-2256


Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.